Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lavandula angustifolia, commonly known as English lavender, is a plant extract with a long history of traditional medicinal use. It is recognized for its antibacterial, antifungal, antioxidant, anti-inflammatory, and antiviral properties. The plant extract is also known for its calming, anxiolytic, and sedative effects. It is being investigated as an ingredient in a nasal spray medical device, developed by The Grasses of Eden Ltd, intended to shorten the duration and mitigate the effects of mild to moderate COVID-19 infection. Additionally, lavender syrup has been studied for improving olfactory dysfunction in COVID-19 patients. Lavender is often sold as an herbal supplement and is classified as an herbal product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lavandula angustifolia.